#16
|
||||
|
||||
÷òî-òî íåëàäíî â øâåäñêîì êîðîëåâñòâå
|
#17
|
|||
|
|||
|
#18
|
||||
|
||||
Ïîëàãàþ, ÷òî âñå äåëî â ñëåäóþùåì:
- BMS should be considered for patients with platelet counts >30,000/ mL who need a non-cardiac procedure, surgery or chemotherapy which can be postponed for >4 weeks. - Newer generation DES should be considered for patients with platelet counts >30,000/mL who are not in immediate need for a non-cardiac procedure, surgery or chemotherapy. ñîãëàñíî êîíñåíñóñó çà 2015, à "Drug-eluting stents pose special problems and should be avoided." çà 2010 ãîä, êîãäà íîâûõ DES èëè íå áûëî, èëè îïûò ñ íèìè áûë åøå íåâåëèê. À òàê âûáîð BMS<->DES çàâèñèò, íóæíà ëè îïåðàöèÿ ÏÕÒ ïàöèåíòó â áëèæàéøèå ìåñÿö-äðóãîé èëè íåò.
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#19
|
|||
|
|||
Ïîíÿòíî. ß ïîäóìàë, ÷òî äàííàÿ ðåêîìåíäàöèÿ (DES) îòíîñèòñÿ ê ñõîäíûì ñ ðàññìàòðèâàåìûì ñëó÷àÿì, êîãäà õèðóðãè÷åñêîå âìåøàòåëüñòâî ðåêîìåíäîâàíî â áëèæàéøåé ïåðñïåêòèâå. À åñëè âîîáùå, òî äà, âîïðîñîâ íåò.
|
#20
|
||||
|
||||
Öèòàòà:
 öåëîì, óäîáíåå âåñòè äèñêóññèþ ñ ìåíüøèìè ïåðåðûâàìè ìåæäó ñîîáùåíèÿìè.
__________________
Àáóãîâ Ñåðãåé Àëåêñàíäðîâè÷. Ðîññèéñêèé Íàó÷íûé Öåíòð Õèðóðãèè èì. àêàäåìèêà Á.Â. Ïåòðîâñêîãî. |
#21
|
|||
|
|||
Íó, â òàêîì ñëó÷àå Âàøà òàêòèêà ïðîòèâîðå÷èò âûøå ïðèâåäåííûì ðåêîìåíäàöèÿì. Ïîòîìó ÷òî â ðàññìàòðèâàåìîì ñëó÷àå ïàöèåíò òàêè èìååò "immediate need for a non-cardiac procedure, surgery or chemotherapy". Êàêîé áû íè áûë "íàâîðî÷åííûé" íîñèòåëü-ïîëèìåð íà DES-å, ýïèòàëèçàöèÿ "ãîëîãî" æåëåçà ïðè ïðî÷èõ ðàâíûõ óñëîâèÿõ ïðîèñõîäèò áûñòðåå. È êàê ñëåäñòâèå - âîçìîæíîñòü áîëåå ðàííåé îòìåíû ÄÀÀÒ.
|
#23
|
|||
|
|||
Âîçìîæíî, ñóùåñòâóåò åù¸ áîëåå "ñâåæèé" êîíñåíñóñ ñ åù¸ áîëåå íîâûìè DES è äðóãèìè ðåêîìåíäàöèÿìè - áóäó ïðèçíàòåëåí çà ññûëêó.
|
#24
|
||||
|
||||
Áîëüíîé íå ÿâëÿåòñÿ êàíäèäàòîì íà íåìåäëåííóþ îïåðàöèþ.
__________________
Àáóãîâ Ñåðãåé Àëåêñàíäðîâè÷. Ðîññèéñêèé Íàó÷íûé Öåíòð Õèðóðãèè èì. àêàäåìèêà Á.Â. Ïåòðîâñêîãî. |
#25
|
||||
|
||||
Âîò òóò åñòü èíòåðåñíàÿ, õîòü è ñëåãêà àôôèëèðîâàííàÿ, êîðîòêàÿ ëåêöèÿ ïî Ïðîäîëæèòåëüíîñòè ÄÀÀÒ. Ñ âïîëíå êîíêðåòíûì ýâèäåíñîì.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |